AI assistant
Sending…
Pulmonx Corp — Director's Dealing 2022
Nov 11, 2022
34428_dirs_2022-11-10_ee9b1960-4a48-4027-b14d-f5722ebd29c1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2022-11-08
Reporting Person: Ferrari Richard (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-08 | Common Stock | P | 5338 | $5.31 | Acquired | 29935 | Direct |
| 2022-11-08 | Common Stock | P | 100 | $5.29 | Acquired | 30035 | Direct |
More from Pulmonx Corp
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 4
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2025
Dec 11
Director's Dealing
2025
Dec 9
Regulatory Filings
2025
Dec 9
Director's Dealing
2025
Dec 4
Director's Dealing
2025
Dec 4